Cargando…

Duodenum-Preserving Pancreatic Head Resection for Benign and Premalignant Tumors—a Systematic Review and Meta-analysis of Surgery-Associated Morbidity

BACKGROUND: Pancreatic benign, cystic, and neuroendocrine neoplasms are increasingly detected and recommended for surgical treatment. In multiorgan resection pancreatoduodenectomy or parenchyma-sparing, local extirpation is a challenge for decision-making regarding surgery-related early and late pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Beger, Hans G., Mayer, Benjamin, Poch, Bertram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661729/
https://www.ncbi.nlm.nih.gov/pubmed/37670106
http://dx.doi.org/10.1007/s11605-023-05789-4
_version_ 1785138040561205248
author Beger, Hans G.
Mayer, Benjamin
Poch, Bertram
author_facet Beger, Hans G.
Mayer, Benjamin
Poch, Bertram
author_sort Beger, Hans G.
collection PubMed
description BACKGROUND: Pancreatic benign, cystic, and neuroendocrine neoplasms are increasingly detected and recommended for surgical treatment. In multiorgan resection pancreatoduodenectomy or parenchyma-sparing, local extirpation is a challenge for decision-making regarding surgery-related early and late postoperative morbidity. METHODS: PubMed, Embase, and Cochrane Libraries were searched for studies reporting early surgery-related complications following pancreatoduodenectomy (PD) and duodenum-preserving total (DPPHRt) or partial (DPPHRp) pancreatic head resection for benign tumors. Thirty-four cohort studies comprising data from 1099 patients were analyzed. In total, 654 patients underwent DPPHR and 445 patients PD for benign tumors. This review and meta-analysis does not need ethical approval. RESULTS: Comparing DPPHRt and PD, the need for blood transfusion (OR 0.20, 95% CI 0.10–0.41, p<0.01), re-intervention for serious surgery-related complications (OR 0.48, 95% CI 0.31–0.73, p<0.001), and re-operation for severe complications (OR 0.50, 95% CI 0.26–0.95, p=0.04) were significantly less frequent following DPPHRt. Pancreatic fistula B+C (19.0 to 15.3%, p=0.99) and biliary fistula (6.3 to 4.3%; p=0.33) were in the same range following PD and DPPHRt. In-hospital mortality after DPPHRt was one of 350 patients (0.28%) and after PD eight of 445 patients (1.79%) (OR 0.32, 95% CI 0.10–1.09, p=0.07). Following DPPHRp, there was no mortality among the 192 patients. CONCLUSION: DPPHR for benign pancreatic tumors is associated with significantly fewer surgery-related, serious, and severe postoperative complications and lower in-hospital mortality compared to PD. Tailored use of DPPHRt or DPPHRp contributes to a reduction of surgery-related complications. DPPHR has the potential to replace PD for benign tumors and premalignant cystic and neuroendocrine neoplasms of the pancreatic head. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11605-023-05789-4.
format Online
Article
Text
id pubmed-10661729
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-106617292023-09-05 Duodenum-Preserving Pancreatic Head Resection for Benign and Premalignant Tumors—a Systematic Review and Meta-analysis of Surgery-Associated Morbidity Beger, Hans G. Mayer, Benjamin Poch, Bertram J Gastrointest Surg Review Article BACKGROUND: Pancreatic benign, cystic, and neuroendocrine neoplasms are increasingly detected and recommended for surgical treatment. In multiorgan resection pancreatoduodenectomy or parenchyma-sparing, local extirpation is a challenge for decision-making regarding surgery-related early and late postoperative morbidity. METHODS: PubMed, Embase, and Cochrane Libraries were searched for studies reporting early surgery-related complications following pancreatoduodenectomy (PD) and duodenum-preserving total (DPPHRt) or partial (DPPHRp) pancreatic head resection for benign tumors. Thirty-four cohort studies comprising data from 1099 patients were analyzed. In total, 654 patients underwent DPPHR and 445 patients PD for benign tumors. This review and meta-analysis does not need ethical approval. RESULTS: Comparing DPPHRt and PD, the need for blood transfusion (OR 0.20, 95% CI 0.10–0.41, p<0.01), re-intervention for serious surgery-related complications (OR 0.48, 95% CI 0.31–0.73, p<0.001), and re-operation for severe complications (OR 0.50, 95% CI 0.26–0.95, p=0.04) were significantly less frequent following DPPHRt. Pancreatic fistula B+C (19.0 to 15.3%, p=0.99) and biliary fistula (6.3 to 4.3%; p=0.33) were in the same range following PD and DPPHRt. In-hospital mortality after DPPHRt was one of 350 patients (0.28%) and after PD eight of 445 patients (1.79%) (OR 0.32, 95% CI 0.10–1.09, p=0.07). Following DPPHRp, there was no mortality among the 192 patients. CONCLUSION: DPPHR for benign pancreatic tumors is associated with significantly fewer surgery-related, serious, and severe postoperative complications and lower in-hospital mortality compared to PD. Tailored use of DPPHRt or DPPHRp contributes to a reduction of surgery-related complications. DPPHR has the potential to replace PD for benign tumors and premalignant cystic and neuroendocrine neoplasms of the pancreatic head. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11605-023-05789-4. Springer US 2023-09-05 2023 /pmc/articles/PMC10661729/ /pubmed/37670106 http://dx.doi.org/10.1007/s11605-023-05789-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review Article
Beger, Hans G.
Mayer, Benjamin
Poch, Bertram
Duodenum-Preserving Pancreatic Head Resection for Benign and Premalignant Tumors—a Systematic Review and Meta-analysis of Surgery-Associated Morbidity
title Duodenum-Preserving Pancreatic Head Resection for Benign and Premalignant Tumors—a Systematic Review and Meta-analysis of Surgery-Associated Morbidity
title_full Duodenum-Preserving Pancreatic Head Resection for Benign and Premalignant Tumors—a Systematic Review and Meta-analysis of Surgery-Associated Morbidity
title_fullStr Duodenum-Preserving Pancreatic Head Resection for Benign and Premalignant Tumors—a Systematic Review and Meta-analysis of Surgery-Associated Morbidity
title_full_unstemmed Duodenum-Preserving Pancreatic Head Resection for Benign and Premalignant Tumors—a Systematic Review and Meta-analysis of Surgery-Associated Morbidity
title_short Duodenum-Preserving Pancreatic Head Resection for Benign and Premalignant Tumors—a Systematic Review and Meta-analysis of Surgery-Associated Morbidity
title_sort duodenum-preserving pancreatic head resection for benign and premalignant tumors—a systematic review and meta-analysis of surgery-associated morbidity
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661729/
https://www.ncbi.nlm.nih.gov/pubmed/37670106
http://dx.doi.org/10.1007/s11605-023-05789-4
work_keys_str_mv AT begerhansg duodenumpreservingpancreaticheadresectionforbenignandpremalignanttumorsasystematicreviewandmetaanalysisofsurgeryassociatedmorbidity
AT mayerbenjamin duodenumpreservingpancreaticheadresectionforbenignandpremalignanttumorsasystematicreviewandmetaanalysisofsurgeryassociatedmorbidity
AT pochbertram duodenumpreservingpancreaticheadresectionforbenignandpremalignanttumorsasystematicreviewandmetaanalysisofsurgeryassociatedmorbidity